|
Sign In to gain access to subscriptions and/or personal tools.
|
Journal of Geriatric Psychiatry and Neurology, Vol. 18, No. 4,
196-201 (2005)
DOI: 10.1177/0891988705281864
Apolipoprotein E 4 and Change in Cognitive Functioning in Community-Dwelling Older Adults
Gary E. Swan, PhD
Center for Health Sciences, SRI International, Menlo Park, California, gary.swan{at}sri.com
Christina N. Lessov-Schlaggar, PhD
Center for Health Sciences, SRI International, Menlo Park, California
Dorit Carmelli, PhD
Center for Health Sciences, SRI International, Menlo Park, California
Gerard D. Schellenberg, PhD
Geriatric Research, Education, and Clinical Center, University of Washington, Seattle
Asenath La Rue, PhD
Wisconsin Alzheimers Institute, University of Wisconsin, Madison
The relationship between apolipoprotein E (APOE) 4 and change in cognition was examined in older men (n = 247; age = 75.0 ± 3.5 years) and women (n = 79; age = 70.8 ± 4.9 years) free of history of stroke. Participants were examined again 4.0 ± 0.5 years later. Exclusion criteria were (1) initial scores on the Mini-Mental State Examination of 23 or less or (2) the presence of the APOE 2/4genotype. Men with 4showed greater decline in some measures of executive function and verbal memory compared to those without 4; women with 4showed greater decline in Trail Making test performance relative to women without the allele. A significant gender x APOE 4interaction was seen for change in performance on short delay cued recall. These results suggest that APOE 4is associated with cognitive decline differently in older adult men and women.
Key Words: cognitive decline elderly gender difference APOE 4

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. F. Jarvik and D. Blazer
Children of Alzheimer Patients: An Overview
J Geriatr Psychiatry Neurol,
December 1, 2005;
18(4):
181 - 186.
[PDF]
|
 |
|
|